BEE-L Archives

Informed Discussion of Beekeeping Issues and Bee Biology

BEE-L@COMMUNITY.LSOFT.COM

Options: Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Content-Type:
multipart/mixed; boundary="Boundary=_0.0_=0034700005735696"
Sender:
Discussion of Bee Biology <[log in to unmask]>
Subject:
From:
Max Watkins <[log in to unmask]>
Date:
Wed, 16 Jul 1997 18:34:19 +0200
MIME-Version:
1.0
Comments:
Reply-To:
Discussion of Bee Biology <[log in to unmask]>
Parts/Attachments:
text/plain (273 bytes) , vitanunc.doc (40 kB)
 
 
     Dear All,
 
 
                Please see the attached document, which explains the
     current bee medicine situation vis-a-vis Sandoz/Ciba-Geigy/Novartis
     and the formation of a new, independent company dedicated to this
     industry.
 
 
     Best regards,
 
 
     Max
 
 
 

ATOM RSS1 RSS2